ABHD11 Knockout Huh-7 Polyclonal Cells are a population of CRISPR/Cas9-edited polyclonal knockout cells derived from the human hepatocellular carcinoma line Huh-7, featuring targeted disruption of the ABHD11 gene. This product provides a loss-of-function model to investigate the biological roles of ABHD11, a serine hydrolase implicated in lipid metabolism. The polyclonal format reflects a heterogeneous pool of edited cells, enabling robust population-level studies without the clonal variability associated with single-cell-derived lines.
The parental Huh-7 cell line is a well-characterized model of human hepatocyte biology, originally isolated from a hepatocellular carcinoma and permissive for hepatitis C virus (HCV) replication. These cells retain many liver-specific functions, including roles in detoxification, protein synthesis, and lipid metabolism, making them particularly valuable for exploring the intersection of host-cell pathways and viral life cycles. The Huh-7 background is extensively employed in preclinical research on liver cancer, metabolic disorders, and infectious disease.
ABHD11 belongs to the alpha/beta hydrolase domain-containing protein family and is predicted to function as a serine hydrolase, potentially catalyzing the hydrolysis of lipid substrates. Although its precise biological substrates remain to be fully defined, ABHD11 is thought to participate in lipid metabolism, and its gene resides within the Williams-Beuren syndrome critical region on chromosome 7. Disruption of ABHD11 may alter cellular lipid composition, influencing membrane organization, lipid droplet formation, and signaling platforms that depend on lipid mediators. In the context of Huh-7 cells, loss of ABHD11 could perturb the host lipid environment, thereby affecting processes such as HCV replication, which is known to hijack lipid droplets for virion assembly.
This knockout model is a powerful tool for dissecting the role of ABHD11 in hepatocyte lipid homeostasis and its downstream effects on pathogenesis. By eliminating ABHD11 expression in Huh-7 cells, researchers can directly assess how this hydrolase contributes to liver cancer cell metabolism and probe its involvement in Williams-Beuren syndrome?Crelated phenotypes. Moreover, the system enables investigation into host factors required for HCV replication, as alterations in lipid metabolism can impact viral entry, RNA replication, and particle production. The polyclonal nature of the product ensures that experimental observations are representative of a diverse editing spectrum, avoiding artifacts from clonal selection.
Researchers can leverage these ABHD11 knockout cells in a variety of downstream applications, including transcriptomic and proteomic profiling, metabolic flux analysis, and lipidomics. Standard validation by western blotting or RT-qPCR can confirm target-gene disruption, while functional studies may involve HCV replication assays, cell viability tests, and lipid uptake or synthesis measurements. This product is well-suited for comparative studies between wild-type and knockout populations cultured in parallel. For further information and custom options, please contact Ascent Research.
